Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Review of Neurobiology|November 10, 2009
Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopiminergic pathway for the treatment of opiate addictionSupriya D Mahajan, Ravikumar Aalinkeel, Jessica L Reynolds, et al.
Pathology Research International|June 11, 2011
Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNASupriya D Mahajan, Ravikumar Aalinkeel, Jessica L Reynolds, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 13, 2012
Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophagesJessica L Reynolds, Wing Cheung Law, Supriya D Mahajan, et al.
International Journal of Nanomedicine|October 12, 2012
Anti-HIV-1 nanotherapeutics: promises and challenges for the futureSupriya D Mahajan, Ravikumar Aalinkeel, Wing-Cheung Law, et al.
Frontiers in Cardiovascular Medicine|June 16, 2023
Comparative analysis of <i>MTP</i> -493G/T and <i>ABCG2</i> 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patientsHariOm Singh, Chandrashekhar Jori, Shyamveer, et al.
Advanced Healthcare Materials|November 28, 2012
Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancerChih-Kuang Chen, Wing-Cheung Law, Ravikumar Aalinkeel, et al.
Immunological Investigations|October 24, 2017
Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-MorbiditySupriya D Mahajan, Ravikumar Aalinkeel, Neil U Parikh, et al.
Current HIV Research|April 30, 2010
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticlesSupriya D Mahajan, Indrajit Roy, Gaixia Xu, et al.
Pageof 7